Request for comments on an issues paper regarding pre-implantation
genetic diagnosis (PGD)
| Title: |
|
|
Request for comments on an issues paper regarding pre-implantation
genetic diagnosis (PGD)
|
| Description: |
|
|
Pre-implantation Genetic Diagnosis (PGD), a technique that
involves the genetic testing of in vitro embryos, is considered
a controlled activity under the Assisted Human Reproduction
Act. The regulation of PGD presents unique regulatory policy
issues because of the social and ethical concerns it raises,
and the speed of advancement in this field. The purpose of
this document is to provide background information and to
identify issues surrounding the regulation of PGD under the
Act. At the end, readers will have an opportunity to respond
to questions. Comments provided will help advance thinking
regarding the regulation of PGD.
|
| Target
Audience: |
|
Comments are welcome from the general public and from individuals
with a particular interest in PGD, such as patients, individuals
born of an AHR procedure, persons with a disability, physicians,
AHR clinic employees, researchers, etc. We would also welcome
input from provincial and territorial officials interested
in or responsible for AHR-related issues.
|
| Type(s)
of activity: |
|
|
| Date: |
|
Beginning: 2005-11-15
|
| Sponsor: |
|
The Assisted Human Reproduction Implementation Office
Policy, Planning and Priorities Directorate
Health Policy Branch
Health Canada
|
| Location: |
|
Online
|
| Contact
Information: |
|
PGD
E-Mail:
ahr-pa@hc-sc.gc.ca
Mail:
The Assisted Human Reproduction Implementation Office
Health Canada, AL 7002A
Ottawa, Ontario K1A 0K9
Fax:
(819) 934-1828
|
|
